<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01027143</url>
  </required_header>
  <id_info>
    <org_study_id>NCCJELK23</org_study_id>
    <nct_id>NCT01027143</nct_id>
  </id_info>
  <brief_title>Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids</brief_title>
  <acronym>NOOA</acronym>
  <official_title>Obesity &amp; Asthma: Nutrigenetic Response to Omega-3 Fatty Acids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nemours Children's Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Office of Dietary Supplements (ODS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Nemours Children's Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will assess the effectiveness of omega-3 fatty acid supplementation in
      controlling asthma symptoms among obese asthmatics, and will assess if a person's genes
      influence response to treatment (personalized medicine). This project may improve our ability
      to treat asthma and our understanding of the link between obesity and asthma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obesity increases the risk for asthma diagnosis in children and adults. With obesity on the
      rise, a better understanding of this association may become critically important to public
      health. We will determine the impact of fish oil-derived Eicosapentaenoic acid (EPA) and
      Docosahexaenoic acid (DHA) on asthma control among obese asthmatics. These omega-3 fatty
      acids have been shown to: reduce inflammation important to asthma and improve asthma outcomes
      in an inconsistent manner across previous smaller studies - results that are consistent with
      a pharmacogenetic influence. There exists evidence that omega-3 fatty acid response displays
      a pharmacogenetic response related to ALOX5 genotype. Preliminary data suggests that obese
      individuals are at greater risk for possessing this same ALOX5 variant and thus obese
      asthmatics may be more responsive to fish oil. We will determine (in a sub-aim) if there
      exists an ALOX5 genotype-related response effect with fish oil. This will be the largest
      clinical trial of omega-3 fatty acid for the treatment of asthma, and the first applying
      pharmacogenetic/nutrigenetic analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">October 22, 2016</completion_date>
  <primary_completion_date type="Actual">October 22, 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Asthma Control Questionnaire (Juniper)</measure>
    <time_frame>baseline, 12 weeks, 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Asthma symptom exacerbation, plasma membrane PUFA composition, spirometry, peak flow, forced oscillation</measure>
    <time_frame>baseline, 12 weeks, 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Asthma</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>omega-3 fatty acids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 softgels (EPA, DHA) twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Soybean oil: 3 matched softgel caps twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>omega-3 polyunsaturated fatty acids</intervention_name>
    <description>ProEPA Xtra 1000mg softgels: 3 softgels twice daily</description>
    <arm_group_label>omega-3 fatty acids</arm_group_label>
    <other_name>ProEPA Xtra 1000mg softgels</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omega-3 Fatty Acid</intervention_name>
    <description>Soybean oil: 3(age 12-25) matched softgel caps twice daily</description>
    <arm_group_label>control</arm_group_label>
    <other_name>Placebo Soybean oil 1000mg soft gels</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 12-25

          -  BMI &gt; 25 (age 18-25) or BMI%&gt;85th (age 12-17) (BMI Liberalized)

          -  Physician diagnosis of persistent asthma

          -  Lung function responsiveness by bronchodilator reversibility or bronchoprovocation
             testing

        Exclusion Criteria:

          -  pregnancy

          -  currently taking LTRA for asthma control

          -  other serious chronic medical condition

          -  bleeding diathesis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason E. Lang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke Children's Hospital and Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nemours Children's Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Hospital/Dept of Pulmonology</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Florida, Morsani College of Medicine</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 3, 2009</study_first_submitted>
  <study_first_submitted_qc>December 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2009</study_first_posted>
  <last_update_submitted>February 10, 2017</last_update_submitted>
  <last_update_submitted_qc>February 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Obesity</keyword>
  <keyword>Pharmacogenetics</keyword>
  <keyword>Nutrigenetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

